title: A human epidermal growth factor receptor 2 expression-based approach to neoadjuvant chemotherapy for operable breast cancer.
authors.affiliation: Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan. tishik@urahp.yokohama-cu.ac.jp
authors.forename: Takashi
authors.initials: T
authors.lastname: Ishikawa
authors.forename: Daisuke
authors.initials: D
authors.lastname: Shimizu
authors.forename: Takeshi
authors.initials: T
authors.lastname: Sasaki
authors.forename: Satoshi
authors.initials: S
authors.lastname: Morita
authors.forename: Mikiko
authors.initials: M
authors.lastname: Tanabe
authors.forename: Ikuko
authors.initials: I
authors.lastname: Ota
authors.forename: Kae
authors.initials: K
authors.lastname: Kawachi
authors.forename: Akinori
authors.initials: A
authors.lastname: Nozawa
authors.forename: Takashi
authors.initials: T
authors.lastname: Chishima
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Ichikawa
authors.forename: Itaru
authors.initials: I
authors.lastname: Endo
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Shimada
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D018943:Anthracyclines / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D003520:Cyclophosphamide / Q000627:therapeutic use; D000077143:Docetaxel; D005260:Female; D006801:Humans; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D043823:Taxoids / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D018943:Anthracyclines; D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D000077143:Docetaxel; D018719:Erb-b2 Receptor Tyrosine Kinases; D043823:Taxoids